These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6201384)
21. [Role of eosinophils in the destruction of schistosomula of Schistosoma mansoni in vivo (preliminary report)]. Andrade ZA; dos Reis MG Mem Inst Oswaldo Cruz; 1984; 79(3):371-3. PubMed ID: 6535919 [TBL] [Abstract][Full Text] [Related]
22. Schistosoma mansoni: human serum and release of proteins from schistosomula. Campana-Pereira MA; Rumjanek FD Exp Parasitol; 1987 Dec; 64(3):267-74. PubMed ID: 3119363 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement. Ramalho-Pinto FJ; Carvalho EM; Horta MF Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():111-6. PubMed ID: 1285336 [TBL] [Abstract][Full Text] [Related]
24. Role of arginase in killing of schistosomula of Schistosoma mansoni. Olds GR; Ellner JJ; Kearse LA; Kazura JW; Mahmoud AA J Exp Med; 1980 Jun; 151(6):1557-62. PubMed ID: 7381366 [TBL] [Abstract][Full Text] [Related]
25. Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components. Golan DE; Brown CS; Cianci CM; Furlong ST; Caulfield JP J Cell Biol; 1986 Sep; 103(3):819-28. PubMed ID: 3745271 [TBL] [Abstract][Full Text] [Related]
26. Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula. Wang W; Kirschfink M; Ruppel A Parasitol Res; 2006 Aug; 99(3):269-74. PubMed ID: 16547731 [TBL] [Abstract][Full Text] [Related]
27. Schistosoma mansoni: a comparative study of artificially transformed schistosomula and schistosomula recovered after cercarial penetration of isolated skin. Brink LH; McLaren DJ; Smithers SR Parasitology; 1977 Feb; 74(1):73-86. PubMed ID: 320543 [TBL] [Abstract][Full Text] [Related]
28. Mast cell-mediated toxicity to schistosomula of Schistosoma mansoni: potentiation by exogenous peroxidase. Henderson WR; Chi EY; Jong EC; Klebanoff SJ J Immunol; 1986 Oct; 137(8):2695-9. PubMed ID: 2428871 [TBL] [Abstract][Full Text] [Related]
29. Assessment of Neuronal Viability Using Fluorescein Diacetate-Propidium Iodide Double Staining in Cerebellar Granule Neuron Culture. Jiajia L; Shinghung M; Jiacheng Z; Jialing W; Dilin X; Shengquan H; Zaijun Z; Qinwen W; Yifan H; Wei C J Vis Exp; 2017 May; (123):. PubMed ID: 28518109 [TBL] [Abstract][Full Text] [Related]
30. A microfluorometric viability assay for isolated human and rat islets of Langerhans. London NJ; Contractor H; Lake SP; Aucott GC; Bell PR; James RF Diabetes Res; 1989 Nov; 12(3):141-9. PubMed ID: 2699586 [TBL] [Abstract][Full Text] [Related]
31. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils. Moser G; Sher A J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624 [TBL] [Abstract][Full Text] [Related]
32. Subclasses of rat IgG active in the killing of schistosomula of Schistosoma mansoni in vitro and in vivo. Horta MF; Ramalho-Pinto FJ J Immunol; 1984 Dec; 133(6):3326-32. PubMed ID: 6491290 [TBL] [Abstract][Full Text] [Related]
33. Schistosoma mansoni: phospholipid methylation and the escape of schistosomula from in vitro cytotoxic reaction. Parra JF; França RC; Kusel JR; Gomez MV; Figueiredo EA; Mota-Santos TA Mol Biochem Parasitol; 1986 Nov; 21(2):151-9. PubMed ID: 3785293 [TBL] [Abstract][Full Text] [Related]
34. Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of human complement. Marikovsky M; Levi-Schaffer F; Arnon R; Fishelson Z Exp Parasitol; 1986 Feb; 61(1):86-94. PubMed ID: 3943595 [TBL] [Abstract][Full Text] [Related]
35. Schistosoma mansoni: loss of the ability of schistosomula to bind mouse complement following intravenous injection into mice. Ruppel A; Rother U; Diesfeld HJ Tropenmed Parasitol; 1984 Mar; 35(1):23-8. PubMed ID: 6369693 [TBL] [Abstract][Full Text] [Related]
36. Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover. Dean DA J Parasitol; 1977 Jun; 63(3):418-26. PubMed ID: 325186 [TBL] [Abstract][Full Text] [Related]
37. Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide. Kvach JT; Munguia G; Strand SH Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):176-82. PubMed ID: 6202650 [TBL] [Abstract][Full Text] [Related]
38. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. Mahmoud AA; Warren KS; Peters PA J Exp Med; 1975 Oct; 142(4):805-13. PubMed ID: 1185104 [TBL] [Abstract][Full Text] [Related]
39. Acquisition of host antigens by young Schistosoma mansoni in mice: correlation with failure to bind antibody in vitro. McLaren DJ; Clegg JA; Smithers SR Parasitology; 1975 Feb; 70(1):67-75. PubMed ID: 1118189 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies demonstrate similarity of surface antigens on different clones of Schistosoma mansoni schistosomula. Smith MA; Clegg JA; Snary D Trans R Soc Trop Med Hyg; 1984; 78(2):187-9. PubMed ID: 6380013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]